Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „concomitant“
Suchtreffer
Begriffe & Kennungen
Bimervax · 4.5 · Concomitant administration of BIMERVAX with other vaccines has not been studied.
Eintrag öffnenBimzelx · 4.5 · Population pharmacokinetic (PK) data analyses indicated that concomitant administration of conventional diseas
Eintrag öffnenBosulif · 4.5 · CYP3A inducers The concomitant use of bosutinib with strong CYP3A inducers (including, but not limited to carb
Eintrag öffnenBosulif · 4.5 · CYP3A inhibitors The concomitant use of bosutinib with strong CYP3A inhibitors (including, but not limited to
Eintrag öffnenBosulif · 4.5 · Caution is warranted if mild CYP3A inducers are used concomitantly with bosutinib.
Eintrag öffnenBosulif · 4.5 · Caution should be exercised if mild CYP3A inhibitors are used concomitantly with bosutinib.
Eintrag öffnenBosulif · 4.5 · Following concomitant administration of a single dose bosutinib with 6 daily doses of 600 mg rifampicin, in 24
Eintrag öffnenBosulif · 4.5 · Proton pump inhibitors (PPIs) Caution should be exercised when administering bosutinib concomitantly with PPIs
Eintrag öffnenBosulif · 4.5 · Selection of an alternate concomitant medicinal product with no or minimal CYP3A enzyme inhibition potential,
Eintrag öffnenBraftovi · 4.5 · CYP substrates Encorafenib is a strong inducer of CYP3A4. Concomitant use with agents that are substrates of C
Eintrag öffnenBridion · 4.8 · Summary of the safety profile Bridion is administered concomitantly with neuromuscular blocking agents and ana
Eintrag öffnenBrilique · 4.5 · 51 CYP3A inducers may decrease exposure and efficacy of ticagrelor, therefore, their concomitant use with tica
Eintrag öffnenBrilique · 4.5 · No data are available on concomitant use of ticagrelor with other active substances that also are potent P-gp
Eintrag öffnenBrilique · 4.5 · No data are available on concomitant use of ticagrelor with other active substances that also are potent P-gp
Eintrag öffnenBrilique · 4.5 · No data are available on concomitant use of ticagrelor with other active substances that also are potent P-gp
Eintrag öffnenBrilique · 4.5 · Other concomitant therapy In clinical studies, ticagrelor was commonly administered with ASA, proton pump inhi
Eintrag öffnenBrilique · 4.5 · Other concomitant therapy In clinical studies, ticagrelor was commonly administered with ASA, proton pump inhi
Eintrag öffnenBrilique · 4.5 · Other concomitant therapy In clinical studies, ticagrelor was commonly administered with ASA, proton pump inhi
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnen